Deng Hongkui
Deng Hongkui is a distinguished cellular biologist leading a research team at Peking University, known for groundbreaking work in regenerative medicine and diabetes treatment. He recently gained international attention for leading a successful clinical trial where a 25-year-old woman with type 1 diabetes started producing her own insulin after receiving a transplant of her own reprogrammed cells, marking a significant milestone in the potential treatment of this challenging autoimmune disease.
Not in the pool (under ¢1).
Recent news mentions
Deng Hongkui's team has developed a new technology for reprogramming human cells for regenerative medicine.
总书记的关切·落地的回响｜力度更大 “四个面向”为基础研究划重点 _光明网
China· 2026-07-15
Deng Hongkui's team has developed a new technology for reprogramming human cells, aiding in regenerative medicine.
力度更大 “四个面向”为基础研究划重点（总书记的关切·落地的回响） --时政--人民网China· 2026-07-14Deng Hongkui led a team at Peking University that successfully transplanted reprogrammed cells into a woman with diabetes type 1.
Se perfila novedoso procedimiento que podría curar la diabetes tipo 1
Mexico· 2025-02-21